Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Return on Invested Capital (2017 - 2024)

vTv Therapeutics' Return on Invested Capital history spans 7 years, with the latest figure at 1.61% for Q4 2024.

  • For Q4 2024, Return on Invested Capital changed N/A year-over-year to 1.61%; the TTM value through Dec 2024 reached 1.61%, changed N/A, while the annual FY2024 figure was 3.89%, N/A changed from the prior year.
  • Return on Invested Capital for Q4 2024 was 1.61% at vTv Therapeutics, down from 1.26% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 2.83% in Q2 2022 and bottomed at 36.41% in Q1 2024.
  • The 4-year median for Return on Invested Capital is 0.26% (2021), against an average of 2.19%.
  • The largest annual shift saw Return on Invested Capital dropped -28bps in 2021 before it skyrocketed 264bps in 2022.
  • A 4-year view of Return on Invested Capital shows it stood at 0.42% in 2020, then skyrocketed by 231bps to 1.39% in 2021, then rose by 19bps to 1.66% in 2022, then plummeted by -197bps to 1.61% in 2024.
  • Per Business Quant, the three most recent readings for VTVT's Return on Invested Capital are 1.61% (Q4 2024), 1.26% (Q3 2024), and 0.99% (Q2 2024).